Journal Profile | |
Journal Title | Molecular Therapy-Oncolytics
|
Journal Title Abbreviations | MOL THER-ONCOLYTICS |
ISSN | 2372-7705 |
h-index | 12 |
CiteScore | CiteScore | SJR | SNIP | CiteScore Rank |
---|
6.70 | 1.982 | 0.955 | Subject field | Quartiles | Rank | Percentile | Category: Medicine Subcategory: Oncology | Q1 | 70 / 331 |
| Category: Medicine Subcategory: Pharmacology (medical) | Q1 | 30 / 237 |
| Category: Medicine Subcategory: Molecular Medicine | Q2 | 46 / 165 |
| Category: Medicine Subcategory: Cancer Research | Q2 | 62 / 198 |
|
|
|
Self-Citation Ratio (2019-2020) | 10.40% |
Official Website | https://www.cell.com/molecular-therapy-family/oncolytics/latest-content |
Online Manuscript Submission | https://mto.msubmit.net/cgi-bin/main.plex |
Open Access | Yes |
Publisher | |
Subject Area | Medicine |
Country/Area of Publication | |
Publication Frequency | |
Year Publication Started | 0 |
Annual Article Volume | 87 |
Indexing (SCI or SCIE) | Science Citation Index Expanded
|
Link to PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=2372-7705%5BISSN%5D |
Average Duration of Peer Review * | Authorized Data from Publisher: Data from Authors: |
Competitiveness * | Data from Authors: |
Useful Links | |
*All review process metrics, such as acceptance rate and review speed, are limited to our user-submitted manuscripts. As such they may not reflect the journals' exact competitiveness or speed. |